• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Radiologix slides in 2Q

Article

Service fees fell 9.1% in the second quarter for Radiologix, a national provider of diagnostic imaging services, to $65 million versus $71.5 million for the second quarter ended June 30. The drop was due primarily to reduced patient volume related to

Service fees fell 9.1% in the second quarter for Radiologix, a national provider of diagnostic imaging services, to $65 million versus $71.5 million for the second quarter ended June 30. The drop was due primarily to reduced patient volume related to increased competition in key markets. The numbers were up about 1%, however, compared with the previous quarter, during which Radiologix generated $64.4 million in service fees. The company achieved net income of $276,000 for the second quarter of 2003, compared with net income of $4.8 million for the previous year period and a net loss of $4.6 million for first quarter 2003. Company executives view the sequential improvement as evidence of stabilization in Radiologix' core business. Net income improved partly as a result of cost-cutting measures.

Related Videos
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Related Content
© 2024 MJH Life Sciences

All rights reserved.